These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35940359)

  • 1. Advances in the treatment of severe combined immunodeficiency.
    Slatter MA; Gennery AR
    Clin Immunol; 2022 Sep; 242():109084. PubMed ID: 35940359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for adenosine deaminase severe combined immune deficiency-An unexpected journey of four decades.
    Kohn DB
    Immunol Rev; 2024 Mar; 322(1):148-156. PubMed ID: 38033164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I treat severe combined immunodeficiency.
    Gaspar HB; Qasim W; Davies EG; Rao K; Amrolia PJ; Veys P
    Blood; 2013 Nov; 122(23):3749-58. PubMed ID: 24113871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term outcomes of severe combined immunodeficiency: therapy implications.
    Heimall J; Cowan MJ
    Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).
    Kohn DB; Gaspar HB
    J Clin Immunol; 2017 May; 37(4):351-356. PubMed ID: 28194615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in newborn screening and immune system reconstitution of severe combined immunodeficiency].
    Huang S; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 48(4):351-357. PubMed ID: 31901036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency.
    Ferrua F; Brigida I; Aiuti A
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):551-6. PubMed ID: 20966749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID.
    Aiuti A; Brigida I; Ferrua F; Cappelli B; Chiesa R; Marktel S; Roncarolo MG
    Immunol Res; 2009; 44(1-3):150-9. PubMed ID: 19224139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation and alternatives for adenosine deaminase deficiency.
    Gaspar HB
    Immunol Allergy Clin North Am; 2010 May; 30(2):221-36. PubMed ID: 20493398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplant for the treatment of adenosine deaminase-deficient severe combined immune deficiency.
    Kuo CY
    Ann Allergy Asthma Immunol; 2021 May; 126(5):449-450. PubMed ID: 33941315
    [No Abstract]   [Full Text] [Related]  

  • 11. Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.
    Carbonaro DA; Jin X; Cotoi D; Mi T; Yu XJ; Skelton DC; Dorey F; Kellems RE; Blackburn MR; Kohn DB
    Blood; 2008 Jun; 111(12):5745-54. PubMed ID: 18356486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal T-Cell Receptor Excision Circle Newborn Screen: What Next?
    Prince BT; Routes JM
    J Allergy Clin Immunol Pract; 2018; 6(1):318-319. PubMed ID: 29310763
    [No Abstract]   [Full Text] [Related]  

  • 13. Personalized hematopoietic stem cell transplantation for inborn errors of immunity.
    Slatter M; Lum SH
    Front Immunol; 2023; 14():1162605. PubMed ID: 37090739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase deficiency: a review.
    Flinn AM; Gennery AR
    Orphanet J Rare Dis; 2018 Apr; 13(1):65. PubMed ID: 29690908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug.
    Ferrua F; Aiuti A
    Hum Gene Ther; 2017 Nov; 28(11):972-981. PubMed ID: 28847159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine Deaminase Deficient SCID with Myocardial Hypertrophy.
    Flinn AM; Flood T; Prendiville T; Gennery AR; Leahy TR
    J Clin Immunol; 2021 Jul; 41(5):1128-1130. PubMed ID: 33709203
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
    Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
    J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe combined immunodeficiency: From its discovery to the perspective].
    Kanegane H; Imai K; Morio T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):145-154. PubMed ID: 28747600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.
    Shaw KL; Garabedian E; Mishra S; Barman P; Davila A; Carbonaro D; Shupien S; Silvin C; Geiger S; Nowicki B; Smogorzewska EM; Brown B; Wang X; de Oliveira S; Choi Y; Ikeda A; Terrazas D; Fu PY; Yu A; Fernandez BC; Cooper AR; Engel B; Podsakoff G; Balamurugan A; Anderson S; Muul L; Jagadeesh GJ; Kapoor N; Tse J; Moore TB; Purdy K; Rishi R; Mohan K; Skoda-Smith S; Buchbinder D; Abraham RS; Scharenberg A; Yang OO; Cornetta K; Gjertson D; Hershfield M; Sokolic R; Candotti F; Kohn DB
    J Clin Invest; 2017 May; 127(5):1689-1699. PubMed ID: 28346229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.